PROTECH C3 + 2I Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

protech c3 + 2i

boehringer ingelheim animal health australia pty. ltd. - leptospirosis - dog - leptospira icterohaemorrhagiae; canine adeno virus type 2; canine coronavirus vaccine - antigen; canine distemper virus strain onderstepoort; canine parvo virus - misc. vaccines or anti sera - leptospirosis - dog - leptospira icterohaemorrhagiae vaccine active 0.0 u; canine adeno virus type 2 vaccine-viral active 0.0 u; canine coronavirus vaccine - antigen vaccine-viral active 0.0 u; canine distemper virus strain onderstepoort vaccine-viral active 0.0 u; canine parvo virus vaccine-viral active 0.0 u - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 1 | canine adenovirus - type 2 | canine coronavirus | canine distemper | canine parvovirus | leptospira icterohaemorrhagiae | parvovirus

Vanguard C4 Injectable Live Vaccine for Dogs Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vanguard c4 injectable live vaccine for dogs

zoetis australia pty ltd - canine distemper virus; canine parainfluenza virus; canine adenovirus type 2 live (cav ii); canine parvovirus - live; gentamicin - misc. vaccines or anti sera - canine distemper virus vaccine-viral active 0.0 u; canine parainfluenza virus vaccine-viral active 0.0 u; canine adenovirus type 2 live (cav ii) vaccine-viral active 0.0 u; canine parvovirus - live vaccine-viral active 0.0 u; gentamicin antibiotic other 30.0 ug/ml - immunotherapy

CANVAC 4 VACCINE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

canvac 4 vaccine

zoetis australia pty ltd - canine adeno virus type 2; canine distemper virus - living; canine parainfluenza virus; canine parvo virus type 2 - misc. vaccines or anti sera - canine adeno virus type 2 vaccine-viral active 0.0 u; canine distemper virus - living vaccine-viral active 0.0 u; canine parainfluenza virus vaccine-viral active 0.0 u; canine parvo virus type 2 vaccine-viral active 0.0 u - immunotherapy - dog | bitch | castrate | puppy - canine distemper | canine parainfluenza | canine parvovirus | hepatitis :- infectious | canine adenovirus type 1 | canine adenovirus type 2 | infectious canine hepatitis | parvovirus

Nobivac DP Plus European Union - English - EMA (European Medicines Agency)

nobivac dp plus

intervet international b.v. - live attenuated canine distemper virus strain onderstepoort: 105.1 – 106.5 tcid50, live recombinant canine parvovirus strain 630a: 105.1 – 106.7 tcid50 - immunologicals for canidae - dogs (small) - for the active immunisation of puppies from 4 weeks of age onwards to prevent clinical signs and mortality of canine distemper virus infection and canine parvovirus infection and to prevent viral excretion following canine distemper virus infection and following canine parvovirus infection.

PARVAC VACCINE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

parvac vaccine

zoetis australia pty ltd - canine parvovirus (inactivated); thiomersal - parenteral liquid/solution/suspension - canine parvovirus (inactivated) vaccine-viral active 0.0 u; thiomersal mercury other 0.1 mg/ml - immunotherapy - dog | bitch | castrate | puppy - canine parvovirus | parvovirus

NOBIVAC DHPPI Ireland - English - HPRA (Health Products Regulatory Authority)

nobivac dhppi

intervet ireland limited - canine distemper virus strain ondertespoort (live), canine adenovirus type 2 strain manhattan lpv3 (live), canine parvovirus strain 154 (live), canine parainfluenza virus strain cornell live - lyophilisate for reconstitution for injection - unknown - canine distemper virus vaccine + canine adenovirus vaccine + canine parvovirus vaccine + canine para - canine - immunological - live vaccine

VANGUARD CPV-L Ireland - English - HPRA (Health Products Regulatory Authority)

vanguard cpv-l

zoetis ireland limited - live canine parvovirus strain nl-35-d, leptospira canicola inactivated, leptospira icterohaemorrhagiae inactivated - solution for injection - %v/v - live canine parvovirus vaccine + inactivated leptospira vaccine - canine - immunological - mixed vaccine (live and inactivated)

Versican Plus DHPPi/L4 European Union - English - EMA (European Medicines Agency)

versican plus dhppi/l4

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live canine parainfluenza virus + live canine parvovirus + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 6 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae and to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa.

Versican Plus DHPPi/L4R European Union - English - EMA (European Medicines Agency)

versican plus dhppi/l4r

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live parainfl.virus + live canine parvovirus + inactivated rabies + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 8–9 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagie serovar icterohaemorrhagiae,to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa and to prevent mortality, clinical signs and infection caused by rabies virus.

PROTECH C2I CANINE CORONAVIRUS & LEPTOSPIRA COPENHAGENI KILLED VACCINE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

protech c2i canine coronavirus & leptospira copenhageni killed vaccine

boehringer ingelheim animal health australia pty. ltd. - leptospira icterohaemorrhagiae antigen; canine coronavirus vaccine - antigen - misc. vaccines or anti sera - leptospira icterohaemorrhagiae antigen vaccine-antigen active 1.0 rp; canine coronavirus vaccine - antigen vaccine-viral active 1.62 rp - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 1 | canine adenovirus - type 2 | canine coronavirus | canine distemper | canine parainfluenza | canine parvovirus | leptospira icterohaemorrhagiae | parvovirus